Skip to main content

ADVERTISEMENT

drug-eluting balloon

Drug-Eluting Balloon for Management of Coronary In-Stent Restenosis in a South Asian Population: Experience From a Tertiary-Care Hospital in Pakistan
02/01/2021

Syed Waqar Ahmed, MBBS, FCPS; Bilal Hussain, MBBS; Bilal Ahmed, PharmD, MSc, MBBS, PhD; Nasir Rahman, MBBS, FCPS; Jamshed Ali, MBBS; Osman Faheem, MD

Syed Waqar Ahmed, MBBS, FCPS; Bilal H...
In this cohort study, we investigated the incidence of target-lesion revascularization and major adverse cardiac event after PCI with DEB for ISR at 1 year and at long-term follow-up in Pakistani patients.
In this cohort study, we investigated the incidence of target-lesion revascularization and major adverse cardiac event after PCI with DEB for ISR at 1 year and at long-term follow-up in Pakistani patients.
In this cohort study, we...
02/01/2021
Journal of Invasive Cardiology
Original Contribution
08/15/2018

Shuangbo Liu, MD1;  Mali Worme, MD1;  Bobby Yanagawa, MD, PhD2;  Naresh Kumar, MD3;  Christopher E. Buller, MD1;  Asim N. Cheema, MD, PhD1;  Akshay Bagai, MD, MHS1

Shuangbo Liu, MD1;  Mali Worme, MD1; ...
To evaluate the efficacy of drug-coated balloon (DEB) for the treatment of drug-eluting stent in-stent restenosis.
To evaluate the efficacy of drug-coated balloon (DEB) for the treatment of drug-eluting stent in-stent restenosis.
To evaluate the efficacy of...
08/15/2018
Journal of Invasive Cardiology